- Sales of cervical plates, lumbar cages and lumbar screws led to highest revenue quarter in company’s history
- Sales of third-party products are growing significantly faster than sales of proprietary products
Performance by Segment
ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows ($MM):
2Q19 | 2Q18 | $ Chg | % Chg | |
Spine | $3.1 | $1.9 | $1.2 | 63.7% |
Orthobiologics | $0.2 | $0.1 | $0.1 | 49.3% |
Total | $3.3 | $2.0 | $1.3 | 62.8% |
1H19 | 1H18 | $ Chg | % Chg | |
Spine | $5.7 | $3.3 | $2.4 | 71.8% |
Orthobiologics | $0.3 | $0.2 | $0.1 | 56.6% |
Total | $6.0 | $3.5 | $2.5 | 70.9% |
Net Earnings Data
Net earnings, inclusive of all revenue, are as follows.
Amt | % of Sales | |
Sales | $3.3 | |
  Cost of Sales | -$2.0 | 60.5% |
  Operating Expenses | -$1.3 | 40.9% |
Net Earnings | $0.0 | -1.4% |
Source: Aurora Spine Corporation; ORTHOWORLD estimates
Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.
Sales of cervical plates, lumbar cages and lumbar screws led to highest revenue quarter in company’s history
Sales of third-party products are growing significantly faster than sales of proprietary products
Performance by Segment
ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows...
- Sales of cervical plates, lumbar cages and lumbar screws led to highest revenue quarter in company’s history
- Sales of third-party products are growing significantly faster than sales of proprietary products
Performance by Segment
ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows ($MM):
2Q19 | 2Q18 | $ Chg | % Chg | |
Spine | $3.1 | $1.9 | $1.2 | 63.7% |
Orthobiologics | $0.2 | $0.1 | $0.1 | 49.3% |
Total | $3.3 | $2.0 | $1.3 | 62.8% |
1H19 | 1H18 | $ Chg | % Chg | |
Spine | $5.7 | $3.3 | $2.4 | 71.8% |
Orthobiologics | $0.3 | $0.2 | $0.1 | 56.6% |
Total | $6.0 | $3.5 | $2.5 | 70.9% |
Net Earnings Data
Net earnings, inclusive of all revenue, are as follows.
Amt | % of Sales | |
Sales | $3.3 | |
  Cost of Sales | -$2.0 | 60.5% |
  Operating Expenses | -$1.3 | 40.9% |
Net Earnings | $0.0 | -1.4% |
Source: Aurora Spine Corporation; ORTHOWORLD estimates
Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
ME
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.